Edwards Lifesciences affirmed FY2025 adjusted EPS guidance of $2.40-$2.50 and raised FY2025 sales guidance from $5.70 billion ...

Eli Lilly's donanemab gets CHMP backing for early Alzheimer's in select patients after trials show reduced disease ...

Despite XRP's (CRYPTO: XRP) recent price cooldown, market commentators remain optimistic about XRP, boosted by growth in ...

The company reported an adjusted loss of 42 cents per share, wider than Wall Street's projected 12-cent loss, according to ...

Blackstone reported second-quarter fiscal year segment revenues of $3.075 billion, up 22% Y/Y, beating the analyst consensus ...

Charter reported quarterly revenue growth of 0.6% year-on-year to $13.77 billion, beating the analyst consensus estimate of ...

They didn't make six figures out of the gate. They weren't pulling in $300,000 tech salaries or inheriting money. But many ...

Coursera reported quarterly earnings of 12 cents per share, which beat the analyst consensus estimate of nine cents.

Centene reported a Q2 loss and pulled its 2025 guidance despite rising revenue, citing higher healthcare costs and shifting ...

Defense contractor Booz Allen Hamilton Holding (NYSE: BAH) reported strong fiscal first-quarter results, exceeding analyst ...

As of July 25, 2025, two stocks in the materials sector could be flashing a real warning to investors who value momentum as a ...

U.S. stock futures were mixed this morning, with the Dow futures gaining around 0.1% on Friday.